← Open Payments lookup

GLORIA MCMILLAN: Open Payments

NPI 1205136363 · BURLINGTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,100 in 131 payments from 13 companies in 2025. Trend: 2023 $1,296 · 2024 $1,840 · 2025 $2,100

Food & beverage: $2,100
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$321
Vanda Pharmaceuticals Inc.12$270
ABBVIE INC.25$265
Otsuka America Pharmaceutical, Inc.13$239
Lundbeck LLC21$228
Janssen Pharmaceuticals, Inc12$218
Neurocrine BioSciences, Inc.9$163
E.R. Squibb & Sons, L.L.C.13$159
Teva Pharmaceuticals USA, Inc.4$74
Alkermes, Inc.4$65

Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, INVEGA SUSTENNA, INGREZZA, COBENFY, ABILIFY MAINTENA.

Industry payments across IA — which companies pay providers there.